Michael Gnant
MD
Professor and Chair, Department of General Surgery; President, Austrian Breast and Colorectal Cancer Study Group (ABCSG)
👥Biography 个人简介
Michael Gnant is the president of ABCSG and led landmark trials establishing bisphosphonates (zoledronic acid) as adjuvant therapy to improve outcomes in postmenopausal breast cancer through bone microenvironment modulation. He led the NATALEE trial demonstrating adjuvant ribociclib benefit in HR-positive early breast cancer. His research integrates endocrine therapy, CDK4/6 inhibition, and bone-targeted agents in the adjuvant breast cancer setting. Gnant is a recognized authority on treatment intensification strategies for early-stage hormone receptor-positive breast cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Michael Gnant 的研究动态
Follow Michael Gnant's research updates
留下邮箱，当我们发布与 Michael Gnant（Medical University of Vienna）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment